Costco share fall following results, while Cardiff Oncology and MillerKnoll shares soar, and more moving stocks
By MarketWatch
Costco failed to raise membership fees as some investors had expected
Here are some of Wednesday's biggest movers:
Stock gainers:
Cardiff Oncology Inc. (CRDF) shares surged 32% on favorable data from two cancer drug trials -- metastatic pancreatic ductal adenocarcinoma and small cell lung cancer treatment.
Shares of MillerKnoll Inc. (MLKN) jumped 14.1% after the furniture maker raised its full-year profit outlook.
Stock decliners:
Morphic Holdings Inc. (MORF) shares fell 5% in premarket trading after the biopharmaceutical company said Chief Executive Praveen Tipirneni would take a medical leave of absence and return to the role after he recovers.
Shares of TrueCar Inc. (TRUE) dropped 4% in late trading on Tuesday after the online car platform said it has a new CFO.
Costco Wholesale Corp. shares (COST) declined 2% in premarket trading. The warehouse club's earnings topped Wall Street estimates, and the company's chief financial officer said theft has not risen "dramatically" over the past year. However, the company, did not raise membership fees as some investors had hoped.
Progress Software Corp.'s (PRGS) stock dipped more than 1% despite net income and revenue that topped analysts' estimates.
-MarketWatch
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
09-27-23 0556ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks